Essential Stock Recommendations for March 25, 2026: Today’s Top Companies to Consider
Investors are eyeing promising opportunities in the stock market as Mehul Kothari, the Deputy Vice President of Technical Research at Anand Rathi Shares and Stock Brokers, has identified three stocks to consider for purchase. Aurobindo Pharma, Infosys, and Larsen & Toubro (L&T) are highlighted as top picks, each showing distinct technical indicators that suggest potential upward movement. With specific buy ranges, stop-loss levels, and target prices provided for each stock, investors are encouraged to assess these recommendations carefully.
Aurobindo Pharma: Breakout with Momentum Confirmation
Aurobindo Pharma has recently experienced a significant breakout after a period of consolidation, signaling a potential upward trend. The stock had been trading within a narrow range, establishing a solid base before this upward movement. Technical indicators are aligning favorably for bullish investors. The Directional Movement Index (DMI) shows a positive bias, indicating strengthening momentum. Additionally, the Relative Strength Index (RSI) has surpassed the 60 mark, reflecting strong buying interest and an improving trend. The Moving Average Convergence Divergence (MACD) has also provided a bullish crossover above the zero line, confirming a shift in momentum toward the upside. Investors are advised to consider buying Aurobindo Pharma within the range of ₹1280 to ₹1260, with a stop-loss set at ₹1235 and a target price of ₹1390.
Infosys: Bullish Divergence Indicating Potential Reversal
Infosys is displaying early signs of a potential reversal, as momentum indicators diverge from the stock’s price action. While the stock has been forming lower lows, the RSI is making higher lows, indicating a bullish divergence and suggesting that selling pressure is diminishing. The MACD has also provided a bullish crossover, reflecting improving momentum and a possible shift in the short-term trend direction. This combination of RSI divergence and MACD confirmation suggests that accumulation is occurring at lower levels. Investors are encouraged to consider buying Infosys within the range of ₹1270 to ₹1240, with a stop-loss at ₹1175 and a target price of ₹1375.
Larsen & Toubro: Oversold Bounce with Positive Divergence
Larsen & Toubro appears to be nearing exhaustion in its recent downtrend, with momentum indicators signaling a potential bounce. Despite a prolonged decline in price, the RSI is not making fresh lower lows, indicating positive divergence and a gradual loss of selling momentum. The MACD is currently positioned in an oversold zone, which typically suggests trend exhaustion and increases the likelihood of a reversal or technical pullback. The alignment of these indicators indicates that the stock may experience a short-term recovery if buying interest emerges at current levels. Investors are advised to consider purchasing Larsen & Toubro within the range of ₹3400 to ₹3350, with a stop-loss set at ₹3250 and a target price of ₹3600.
(Disclaimer: Recommendations and views on the stock market, other asset classes, or personal finance management tips given by experts are their own. These opinions do not represent the views of Observer Voice.)
Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.
Follow Us on Twitter, Instagram, Facebook, & LinkedIn
